Category: Uncategorized

InVera Medical is gearing up for an exhilarating ride on the wave of innovation, and the excitement is building.

LSI Emerging Medtech Summit USA 2024 isn’t just a gathering; it’s becoming a rendezvous of brilliance, where innovative minds will collide, dreams will take flight, and InVera will pitch its heart out. As Mark Twain once wisely said, “The secret of getting ahead is getting started”. Well, here we are, on the brink of diving into the future of healthcare with gusto.

With investors to meet, friends to reunite with, and a tidal wave of enthusiasm propelling us forward, #LSIUSA2024 is about to transform Dana Point into the epicentre of healthcare innovation, one pitch at a time!

Read more via LinkedIn:  InVera Medical at LSI USA ’24 (LinkedIn)

*Investigational device not for sale in US or any international markets.

For more information please contact info@inveramedical.com

Follow us on social media:

LinkedIn: https://www.linkedin.com/company/invera-medical

X: https://twitter.com/InVeraMedical

InVera Medical is honoured to participate in the prestigious VEITH Symposium in New York, an international gathering of leaders in vascular and endovascular surgery and a hub for ground-breaking advancements in the treatment of vascular disease. We’re thrilled to announce that Dr. Lowell Kabnick will feature the latest updates on our current clinical development pathway in session #70 titled “New Devices and Not Yet Approved” on Thursday, November 16, 2023, from 2:07 PM to 2:12 PM.

Join us for a glimpse into the future of venous disease treatment as we share the latest updates on our revolutionary technology. Discover the progress from our recent trials and our strategic plans for the journey ahead.

At InVera Medical, we’re committed to redefining the standards of care for Chronic Venous Disease, and events like VEITHsymposium provide a valuable platform to showcase our advancements and connect with fellow vascular innovators.

Stay tuned for more updates and insights as we continue our mission to make a meaningful impact in venous medicine!

Read more here: https://www.linkedin.com/posts/invera-medical_veithsymposium-inveramedical-vascularinnovation-activity-7129826584252821504-gKwi?utm_source=share&utm_medium=member_desktop

*Investigational device not for sale in US or any international markets.

InVera Medical are delighted to feature in the latest American Venous Forum | AVF Vein Specialist Newsletter on Emerging Technology. We are excited to bring a mechanical-only venous ablation device to patients with Chronic Venous Disease.

A uniquely non-thermal, non-chemical and non-implant technology with massive potential to improve treatment outcomes.

Read more: https://www.venousforum.org/resources/news-publications/newsletter-2023-09-page2/#amsel

*Investigational device not for sale in US or any international markets

InVera Medical had an amazing week at the International Union of Phlebology (UIP) 2023 meeting in Miami. Our CMO, Dr. Nigel Phelan, met with many leading experts at the forefront of venous disease treatments, gaining great clinical insights into the current treatment landscape. Special thanks to Lowell Kabnick MD for presenting our latest updates in the Emerging Technology and Global Abstracts sessions.

Read more about UIP 2023: https://www.myavls.org/annual-congress-2023.html

*Investigational device not for sale in US or any international markets

InVera Medical had the incredible opportunity to attend the LSI Europe event in stunning Barcelona that combined the best of innovation with the pleasures of good food and wine.

We were overwhelmed by the high level of interest in our groundbreaking venous ablation treatment technology. It was a fantastic platform to connect with potential innovation partners and investors who share our passion for revolutionizing healthcare.

Read more: https://www.linkedin.com/posts/stephen-cox_lsieurope-lsieurope-medtechinnovation-activity-7113172835384098816-VmPd?utm_source=share&utm_medium=member_desktop

*Investigational device not for sale in US or any international markets

Ireland is home to indigenous inventors and innovators who are pushing the boundaries when it comes to medtech and life sciences.

Read about InVera Medical who are named among a number of examples of indigenous Irish healthcare, pharma, medtech and life sciences businesses with an export focus here: https://www.thinkbusiness.ie/articles/irish-medical-life-sciences-innovators/

*Investigational device not for sale in US or any international markets

Recently, InVera Medical successfully attained the ISO 13485:2016 certification from BSI (British Standards Institution), an international notified body. ISO 13485 is an internationally recognised standard for quality management systems within the medical device industry. This achievement marks a crucial milestone preceding the market approval and registration of our InVera device in both the United States and Europe.

Expressing the significance of this accomplishment, Stephen Cox, CEO of InVera Medical remarked, “This certification is a testament to the culmination of years of dedicated effort, transforming our groundbreaking solution – the world’s first medical device to utilise the body’s biological response to treat varicose veins and venous ulcers without harmful side effects and translated that into an internationally recognised platform that is ready for manufacturing and human use”.

Aisling O’Sullivan, Director of Regulatory and Quality, played a pivotal role in initiating, developing, and executing the Quality Management System with the support of the InVera Medical team. Commenting on the announcement she emphasised, “ISO 13485:2016 certification establishes a robust foundation for the company to meet our customer requirements, ensure regulatory compliance, and foster excellence in day-to-day operational practices. Importantly, it represents a key step in delivering on our core values of patient safety.”  

We are thrilled that InVera Medical have been awarded the ISO 13485 qualification, affirming our commitment to maintaining a Quality Management System that consistently meets customer and regulatory standards throughout the InVera device’s lifecycle. With ISO 13485:2016 certification, the InVera Medical team will continue to increase its investment in quality management, delivering high-quality design, development, and manufacturing that not only meets but exceeds all specifications and regulatory requirements but makes product safety one of the company’s highest priorities.

*Investigational device not for sale in US or any international markets

What an incredible week at the MedTech Strategist Innovation Summit Dublin 2023!

It was great meeting investors and corporates who showed a lot of interest in our upcoming fundraise, and we received fantastic feedback on our latest progress and plans for the future. As always, there’s nothing quite like meeting people face-to-face to build long-lasting relationships.

During the main Medtech Strategist Innovation Summit event InVera Medical had the pleasure of participating in the “The Future of Medtech” panel hosted by Enterprise Ireland, where we discussed the latest advancements and trends in the industry with other innovative companies.

One of the interesting topics we discussed on the panel was the role of AI and machine learning in medtech, and ChatGPT’s potential in this area. As a language model trained on a vast amount of medical data, ChatGPT, AutoGPT, and other intelligent agent variants have the ability to assist medtech professionals in their decision-making processes and efficiencies as part of goals to improve patient outcomes.

However, it’s important to remember that while AI and machine learning can certainly enhance the field of medtech, they should never replace the human touch and expertise of innovation. It’s all about finding the right balance between technology and human interaction.

As Socrates once said, “To find yourself, think for yourself” and “I know one thing, that I know nothing.” In the ever-changing world of medtech, it’s important to keep an open mind and always be willing to learn and innovate.

We’re already looking forward to next year’s summit and the opportunity to continue collaborating with the amazing minds in our industry.

InVera Medical is developing a catheter-based therapy for chronic venous disease. The device uses non-thermal energy to disrupt the inner vessel lining, resulting in natural scarring that diverts blood flow away from diseased vessels.

Watch Stephen’s pitch back here: https://www.lifesciencemarketresearch.com/videos/stephen-cox-in-vera-medical-lsi-usa-23

*Investigational device not for sale in US or any international markets

The Irish Medtech Association, the Ibec group that represents the medtech sector, Enterprise Ireland and IDA Ireland has announced the finalists for Medtech Rising: The Irish Medtech Awards 2022.

The Irish Medtech Association, the IBEC group that represents the Medtech sector, Enterprise Ireland and IDA Ireland has announced the finalists for Medtech Rising: The Irish Medtech Awards 2022. InVera Medical are delighted to be announced as a finalist in the Emerging Medtech Company category.

Read More: https://www.med-technews.com/news/medtech-ireland/finalists-announced-for-the-irish-medtech-awards-2022/

One of four Irish businesses to receive funding through an EIC Accelerator round earlier this year, InVera Medical was previously known as Venari Medical has developed a minimally invasive medical device that it hopes can tackle chronic venous disease at early and extreme stages. The start-up was founded in 2017 by Stephen Cox, Nigel Phelan and Sean Cummins.

Read more: https://www.siliconrepublic.com/start-ups/healthcare-startups-medical-devices-health-europe

*Investigational device not for sale in US or any international markets

The Galway medtech has developed a faster and less invasive treatment of chronic venous disease which affects 12 million people in Europe and the US, by Donal MacNamee.

Read the article in full at https://www.businesspost.ie/post-plus/invera-medical-targets-e17m-game-changer-funding-for-device-to-treat-varicose-veins/